as of 03-12-2026 3:21pm EST
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.
| Founded: | 1976 | Country: | United States |
| Employees: | N/A | City: | BIRMINGHAM |
| Market Cap: | 1.2B | IPO Year: | 2000 |
| Target Price: | $25.00 | AVG Volume (30 days): | 572.3K |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | quarterly |
| EPS: | 0.99 | EPS Growth: | -3.88 |
| 52 Week Low/High: | $15.30 - $24.77 | Next Earning Date: | 05-25-2026 |
| Revenue: | $1,098,028,000 | Revenue Growth: | -4.55% |
| Revenue Growth (this year): | -5.31% | Revenue Growth (next year): | -2.38% |
| P/E Ratio: | 24.78 | Index: | N/A |
| Free Cash Flow: | -35206000.0 | FCF Growth: | N/A |
SEC 8-K filings with transcript text
Feb 23, 2026 · 100% conf.
1D
+4.88%
$25.59
5D
+4.97%
$25.61
20D
+5.88%
$25.84
pra-202602230001127703false00011277032026-02-232026-02-23
Washington, D.C. 20549
8-K
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 23, 2026
ProAssurance Corporation (Exact name of registrant as specified in its charter)
Delaware001-1653363-1261433 (State of Incorporation) (Commission File No.) (IRS Employer I.D. No.)
100 Brookwood Place,Birmingham, AL35209 (Address of Principal Executive Office )(Zip code)
Registrant’s telephone number, including area code: (205) 877-4400
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Securities Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-(c) under the Exchange Act (17CFR 240.13e-(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per sharePRANew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
1
On February 23, 2026 we issued a news release reporting the results of our operations for the quarter and year ended December 31, 2025. The text of the release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
99.1 News release issued on February 23, 2026 reporting results of ProAssurance's operations for the quarter ended December 31, 2025. The information we are furnishing under Item 9.01 of this Current Report on Form 8K, including Exhibit 99.1, is not be deemed to be “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934 (the “Exchange Act”) as amended, or otherwise subject to the liability of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 23, 2026
by: /s/ Jeffrey P. Lisenby
Jeffrey P. Lisenby General Counsel
2
Nov 4, 2025
pra-202511040001127703false00011277032025-11-042025-11-04
Washington, D.C. 20549
8-K
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 5, 2025
ProAssurance Corporation (Exact name of registrant as specified in its charter)
Delaware001-1653363-1261433 (State of Incorporation) (Commission File No.) (IRS Employer I.D. No.)
100 Brookwood Place,Birmingham, AL35209 (Address of Principal Executive Office )(Zip code)
Registrant’s telephone number, including area code: (205) 877-4400
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Securities Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-(c) under the Exchange Act (17CFR 240.13e-(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per sharePRANew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
1
On November 4, 2025 we issued a news release reporting the results of our operations for the quarter ended September 30, 2025. The text of the release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
We also have updated our online disclosure of our entire investment portfolio to provide details of our holdings through September 30, 2025. The disclosure is available under Quarterly Results in the Financial Information section of our Investor Relations website.
99.1 News release issued on November 4, 2025 reporting results of ProAssurance's operations for the quarter ended September 30, 2025. The information we are furnishing under Items 7.01 and 9.01 of this Current Report on Form 8K, including Exhibit 99.1, is not be deemed to be “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934 (the “Exchange Act”) as amended, or otherwise subject to the liability of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 4, 2025
by: /s/ Jeffrey P. Lisenby
Jeffrey P. Lisenby General Counsel
2
Nov 7, 2024
pra-202411070001127703false00011277032024-11-072024-11-07
Washington, D.C. 20549
8-K
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 7, 2024
ProAssurance Corporation (Exact name of registrant as specified in its charter)
Delaware001-1653363-1261433 (State of Incorporation) (Commission File No.) (IRS Employer I.D. No.)
100 Brookwood Place,Birmingham, AL35209 (Address of Principal Executive Office )(Zip code)
Registrant’s telephone number, including area code: (205) 877-4400
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Securities Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-(c) under the Exchange Act (17CFR 240.13e-(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per sharePRANew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
1
On November 7, 2024 we issued a news release reporting the results of our operations for the quarter and nine months ended September 30, 2024. The text of the release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
We are furnishing investor presentation materials to be used starting November 7, 2024 as Exhibit 99.2. The presentation is available under Presentations under the News & Presentation Materials tab of the Investor Relations section of our website (http://investor.proassurance.com). We also have updated our online disclosure of our entire investment portfolio to provide details of our holdings through September 30, 2024. The disclosure is available under Quarterly Investment Supplements under the Financial Information section of the Investor Relations section of our website.
99.1 News release issued on November 7, 2024 reporting results of ProAssurance's operations for the three and nine months ended September 30, 2024. 99.2 Presentation materials we will begin using on November 7, 2024. The information we are furnishing under Items 7.01 and 9.01 of this Current Report on Form 8K, including Exhibits 99.1and 99.2, are not be deemed to be “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934 (the “Exchange Act”) as amended, or otherwise subject to the liability of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.
Pursuant to the requirements of the Securities Exchange act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 7, 2024
by: /s/ Jeffrey P. Lisenby
Jeffrey P. Lisenby General Counsel
2
See how PRA stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "PRA ProAssurance Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.